Completed NA INTERVENTIONAL 2-arm NCT03677011

Andrositol® TEST as Diagnostic Assay to Predict the Fertilization Potential in IVF

Andrositol® TEST as Diagnostic Assay to Predict the Fertilization Potential of the Sperm in the in Vitro Fertilization (IVF) Procedures.

Sponsor: Lo.Li.Pharma s.r.l

Conditions Male Infertility

Interventions Andrositol® Test

Updated 7 times since 2018 Last updated: Apr 5, 2022 Started: Jul 1, 2018 Primary completion: Sep 1, 2021 Completion: Oct 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Male Infertility, this trial is completed. The trial is conducted by Lo.Li.Pharma s.r.l and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — May 2022 [monthly]

Unknown Status NA
Aug 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2020 — Aug 2020 [monthly]

Recruiting NA
Oct 2018 — Feb 2020 [monthly]

Recruiting NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lo.Li.Pharma s.r.l

Data source: Lo.Li.Pharma s.r.l

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pasadena, United States